This is a dummy test for home page
(Reuters) – U.S. drugmaker Gilead Sciences Inc will use Sangamo Therapeutics Inc’s gene-editing technology to develop cancer treatments in a deal potentially worth about $3 billion to Sangamo, the companies said on Thursday.
Source: Reuters Medical News
KAMPALA (Reuters) – Twenty-six refugees from the Democratic Republic of Congo have died in a camp in Uganda from acute diarrhea, and hundreds more cases have been registered, an official from the United Nations refugee agency UNHCR said on Thursday.
Source: Reuters Medical News
JOHANNESBURG (Reuters) – The death toll from an outbreak of the food-borne disease listeria in South Africa has more than doubled from previous numbers given in January to 172 deaths, the government said on Thursday.
Source: Reuters Medical News
COPENHAGEN/LONDON (Reuters) – The world’s largest diabetes drugmaker, Novo Nordisk, on Thursday presented the first successful data from a large final-stage study of a pill it hopes will transform the diabetes market.
Source: Reuters Medical News
AMSTERDAM (Reuters) – Dutch prosecutors on Thursday rejected a call by civil groups, hospitals and the city of Amsterdam to open a criminal case against major tobacco companies, saying the firms had adequately warned smokers of the health risks.
Source: Reuters Medical News
LONDON (Reuters) – A vast research study that sought to settle a long-standing debate about whether or not anti-depressant drugs really work has found they are indeed effective in relieving acute depression in adults.
Source: Reuters Medical News
(Reuters Health) – The amount of foods containing sugars or other carbohydrates that a woman eats has nothing to do with the likelihood she will start experiencing premenstrual syndrome (PMS), researchers say.
Source: Reuters Medical News
(Reuters) – Nearly 70 percent of children with potentially fatal acute Graft Versus Host Disease responded to treatment with an experimental stem cell therapy from Mesoblast Ltd, meeting the primary goal of a late-stage U.S. trial, the Australian company announced on Wednesday.
Source: Reuters Medical News
(Reuters Health) – The expensive anti-clotting drug Xarelto is no better than common aspirin when it comes to preventing painful and potentially-deadly clots in people who have just had total hip or total knee replacement surgery, according to a new Canadian study.
Source: Reuters Medical News
(Reuters) – AstraZeneca Plc said on Wednesday an advisory committee of the U.S. Centers for Disease Control and Prevention recommended the use of its FluMist Quadrivalent vaccine in the upcoming flu season, reversing its earlier position.
Source: Reuters Medical News